Skip to main content
Where your money goes
Drug Types and Effects
Public Health Crisis
Science of Addiction
All About Opioids
All About Naloxone
Substance Use Disorder Treatment
Medication Assisted Treatment (MAT)
First 90 Days
Become an Ambassador
Fundraise for Shatterproof
Rise Up Against Addiction 5K Walk/Run
Create Your Own Fundraiser
New York City Marathon
Shatterproof Benefit at Richards of Greenwich
Volunteer with Us
Real Costs of Substance Use in Your Workplace
Workplace Cost Calculator
Take Action in Your Workplace
What Employers Can Do
Learn About the Issue
Update Your Workplace Program
Structure Benefits to Address Substance Use Disorder
Real Cost Methodology Paper
Substance Use Disorder Treatment Task Force
About the Task Force
National Principles of Care
Family Support Groups
Become an Ambassador
Shatterproof’s leadership team consists of doctors, executives, addiction specialists, and people affected by substance use disorders. They are committed to ending the devastation caused by the disease of addiction.
Board of Directors
Managing Director and CIO, ICG
President and a member of the Board of Directors of The Suzanne Wright Foundation
Jonathan E. Fielding, M.D.
Co-Director, UCLA Center for Healthier Children, Families and Communities
Gary Henson, CFA
President, Tortoise Investments
Founder, Chairman and CEO
Chair, Real Estate Capital Markets Group, Goodwin Proctor LLP
CEO, HEI Hotels & Resorts
Cathy Siegel Weiss
President of Shaker Square, LLC
NFL Executive Vice President of International
Board of Advisors
Donald Berwick, M.D., M.P.P.
Former Administrator, Centers for Medicare and Medicaid Services; Former President & CEO, Institute for Healthcare Improvement
Executive Vice President and Chief Financial Officer, City National Bank
President of Finkelstein & Co.
Mark G. Miller
Former Managing Director of Citigroup Global Markets and Blackrock Inc
Thomas J. Corcoran, Jr.
TCOR Hotel Partners
The Honorable Patrick Kennedy
Former Congressman; Co-Founder, One Mind for Research
Robert L. DuPont, M.D.
First Director, National Institute of Drug Abuse; Former White House Drug Chief
Executive Director of Media and Innovation for Mercy College
co-CEO, Mitchells Stores
CEO of Women’s Intimate Apparel for USA and Great Britain and President of the Company’s Delta Galil USA segment
Co-head of Crow Holdings Capital Investment Partners
SVP, Wealth Management, Merrill Lynch
Former CEO, American Heart Association
Owner of Bridge Strategic Communications
Amelia Arria, Ph.D.
Associate Professor, Department of Behavioral and Community Health; Director, Center on Youth Adult Health and Development, University of Maryland School of Public Health
Alisa Bahl, Ph.D.
Senior Vice President, Clinical Solutions, OptumHealth
SVP and Chief Pharmacy Officer, OptumRX
Richard Catalano, Ph.D.
Professor & Director, Social Development Research Group, University of Washington
Larry Gentilello, M.D.
Professor of Surgery, Adjunct Professor of Management, Policy and Community Health, University of Texas; Former President, Society for Prevention Research
Martin H. Rosenzweig, MD
Senior Behavioral Medical Director with Optum
David Hawkins, Ph.D.
Professor & Founding Director, Social Development Research Group, University of Washington
Thomas McLellan, Ph.D.
Founder, Treatment Research Institute
Douglas Nemecek, M.D., MBA
Senior Medical Director, CIGNA
Opioid Overdose Advisory Board
Executive Director, Kentucky Office of Drug Control Policy
Andrew Kolodny, M.D.
Co-Director of The Opioid Policy Research Collaborative at the Heller School for Social Policy and Management
John L. Eadie
Director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University
Sign up to receive our newsletter and updates to get involved.
Help make our families Shatterproof.